Action Revance Therapeutics - RVNC

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

3,65

Prix Achat

3,84

Prix Vente

3,10

Volume échangé

0,00 Fourchette du Jour 0,00

2,30 Plage de 52 semaines 6,65

Clôture Veille

3,65

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

1 630 480

Volume financier

VWAP

Form 15-12G - Securities registration termination [Section 12(g)]

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your...

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	3.65	3.65	3.65	0	0	CS
4	0	0	3.65	3.65	3.65	0	0	CS
12	0.56	18.1229773463	3.09	3.7	3.03	1630480	3.4536406	CS
26	-2.93	-44.5288753799	6.58	6.59	3.01	2479557	4.30574619	CS
52	-2.58	-41.4125200642	6.23	6.65	2.3	2717810	4.70264623	CS
156	-12.12	-76.8547875713	15.77	37.98	2.3	1843692	12.19700455	CS
260	-13.03	-78.1175059952	16.68	37.98	2.3	1352942	13.96432115	CS

RVNC - Frequently Asked Questions (FAQ)

What is the current Revance Therapeutics share price?

The current share price of Revance Therapeutics is US$ 3,65

What is the 1 year trading range for Revance Therapeutics share price?

Revance Therapeutics has traded in the range of US$ 2,30 to US$ 6,65 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
RGCRegencell Bioscience Holdings Ltd	US$ 14,25 (239,29%)	23,33M
LZMHLZ Technology Holdings Ltd	US$ 13,29 (62,47%)	860,76k
HMRHeidmar Maritime Holdings Corporation	US$ 4,08 (60,00%)	84,65M
ICONIcon Energy Corporation	US$ 0,1356 (45,65%)	85,57M
AVAHAveanna Healthcare Holdings Inc	US$ 5,15 (37,70%)	3,4M
CMCTCreative Media and Community Trust Corporation	US$ 0,35 (-46,15%)	2,1M
SPHLSpringview Holdings Ltd	US$ 0,7194 (-41,98%)	2,7M
ADTXAditxt Inc	US$ 0,0339 (-40,32%)	118,87M
ULYUrgent ly Inc	US$ 0,3086 (-39,44%)	1,76M
PSTVPlus Therapeutics Inc	US$ 0,7501 (-38,01%)	3,89M
SPGCSacks Parente Golf Inc	US$ 0,1388 (28,52%)	365,79M
NVDANVIDIA Corporation	US$ 115,58 (-0,14%)	298,57M
INTCIntel Corporation	US$ 23,70 (14,60%)	243,25M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 8,585 (-6,07%)	217,49M
TQQQProShares UltraPro QQQ	US$ 57,79 (-5,46%)	121,22M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Revance Therapeutics Inc (RVNC)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

RVNC Dernières nouvelles

Form 15-12G - Securities registration termination [Section 12(g)]

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 15-12G - Securities registration termination [Section 12(g)]

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

RVNC - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Revance Therapeutics Inc (RVNC) Cours

Revance Therapeutics Inc (RVNC)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

RVNC Dernières nouvelles

Form 15-12G - Securities registration termination [Section 12(g)]

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 15-12G - Securities registration termination [Section 12(g)]

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

RVNC - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités